employee
employee
Pirogov Russian National Research Medical University
employee
Russian Federation
GRNTI 76.33 Гигиена и эпидемиология
GRNTI 76.03 Медико-биологические дисциплины
OKSO 31.06.2001 Клиническая медицина
OKSO 31.08.08 Радиология
OKSO 32.08.12 Эпидемиология
OKSO 14.04.02 Ядерные физика и технологии
BBK 534 Общая диагностика
BBK 51 Социальная гигиена и организация здравоохранения. Гигиена. Эпидемиология
TBK 5712 Медицинская биология. Гистология
TBK 5734 Медицинская радиология и рентгенология
TBK 6212 Радиоактивные элементы и изотопы. Радиохимия
TBK 5708 Гигиена и санитария. Эпидемиология. Медицинская экология
Purpose: to determine the role of nuclear medicine methods in the diagnosis and quality control of treatment and rehabilitation of patients with complications after coronavirus diseasr (COVID-19) The article provides a brief analysis of the incidence of COVID-19 and highlights the role of diagnosis, treatment and rehabilitation of patients suffering from the consequences of coronavirus diseasr after the end of the pandemic. The most common clinical manifestation of coronavirus diseasr is bilateral interstitial pneumonia, one of the complications of which is the development of acute respiratory distress syndrome, its pathogenesis is highlighted. It is also noted that the leading link in the development of the disease is a systemic lesion of the endothelial vascular wall, which is the cause of thrombosis and its complications, primarily pulmonary embolism, ischemic brain infarctions and cardiovascular catastrophes. Specific methods of radionuclide diagnostics are described for individual organs and systems: respiratory, cardiovascular, brain, and others. The need to diagnose and control the quality of treatment and rehabilitation of patients with post-inflammatory changes in the parenchyma of internal organs and a decrease in their functional ability due to sclerotic changes, patients with changes in the state due to the transition of inflammation to the chronic stage, as well as with an overactive immune response to inflammatory changes. Conclusion: at the stage of diagnosis and treatment of the consequences of a previous coronavirus diseasr and subsequent rehabilitation, molecular imaging methods are essential in a complex of studies.
COVID-19, diagnostics nuclear medicine, respiratory system, cardiovascular system, brain
1. Batawi S, Tarazan N, Al-Raddadi R, et al. Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS). Health and Quality of Life Outcomes. 2019;17(1):101. DOIhttps://doi.org/10.1186/s12955-019-1165-2 PMID:31186042
2. Bikdeli B, Madhavan M, Jimenez D, et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;75(23):2950-73. DOIhttps://doi.org/10.1016/j.jacc.2020.04.031 PMID:32311448
3. Bikdeli B, Madhavan M, Jimenez D, et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up. J Am Coll Cardiol. 2020;75(23):2950-2973. DOIhttps://doi.org/10.1016/j.jacc.2020.04. 031 PMID:16032747
4. Dundamadappa S, Kaw G, Koteyar S, Goh J, Chee T. High-Resolution CT (HRCT) in Severe Acute Respiratory Syndrome (SARS) Patients Post Hospital Discharge: A Long-term Follow-up Study | Request PDF. In: Radiological Society of North America 2004 Scientific Assembly and Annual Meeting. RSNA; 2004.
5. Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurology. 2020;77(6):683. DOIhttps://doi.org/10.1001/jamaneurol.2020.1127 PMID:32275288
6. Montalvan V, Lee J, Bueso T, de Toledo J, Rivas K. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review. Clinical Neurology and Neurosurgery. 2020;194:105921. DOIhttps://doi.org/10.1016/j.clineuro.2020.105921 PMID: 32422545
7. Oxley TJ, Mocco J, Majidi S, et al. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. N Eng J Med. 2020;382(20):e60. DOIhttps://doi.org/10.1056/NEJMc2009787 PMID:32343504
8. Carvalho A, Alqusairi R, Adams A, et al. SARS-CoV-2 Gastrointestinal Infection Causing Hemorrhagic Colitis: Implications for Detection and Transmission of COVID-19 Disease. Am J Gastroenterol. 2020;115(6):942-6. DOIhttps://doi.org/10.14309/ajg.000000 0000000667 PMID:32496741
9. Ronco C, Reis T, Husain-Syed F. Management of acute kidney injury in patients with COVID-19. Lancet Respir Med. 2020; 8(7):738-42. DOIhttps://doi.org/10.1016/S2213-2600(20)30229-0PMID:32416769
10. Konstantinides S, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543-603. DOI:10.1093 /eurheartj/ehz405 PMID:31504429
11. Liu C, Zhou J, Xia L, Cheng X, Lu D. 18F-FDG PET/CT and Serial Chest CT Findings in a COVID-19 Patient with Dynamic Clinical Characteristics in Different Period. Clinical Nuclear Medicine. 2020;45(6):495-6. DOIhttps://doi.org/10.1097/RLU.0000000000003068 PMID:32332319
12. Naghavi M, Libby P, Falk E, et al. From Vulnerable Plaque to Vulnerable Patient. Circulation. 2003;108(14):1664-72. DOIhttps://doi.org/10.1161/01.CIR.0000087480.94275.97 PMID:14530185
13. Slart RHJA, Slart RHJA, Glaudemans AWJM, et al. FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Molec Imaging. 2018;45(7):1250-69. DOIhttps://doi.org/10.1007/s00259-018-3973-8 PMID:29637252
14. Papathanasiou ND, Du Y, Menezes LJ, et al. 18 F-Fludeoxyglucose PET/CT in the evaluation of large-vessel vasculitis: diagnostic performance and correlation with clinical and laboratory parameters. Br J Radiol. 2012;85(1014):e188-e194. DOIhttps://doi.org/10.1259/bjr/16422950 PMID:21385914
15. Assessment of brain SPECT: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 1996;46(1):278-85. DOI:10.1212/ WNL.46.1.278 PMID:8559404
